Legal Opinion
Bayer AG v. Dr. Reddy's Laboratories, Ltd.
District Court, D. Delaware
Decided October 25, 2007No. Civ. 04-179-SLRPublishedCited by 1 opinion
1Opinion of the Court
OPINION
SUE L. ROBINSON, District Judge.
I.INTRODUCTION
This action arises out of the filing of an Abbreviated New Drug Application (“ANDA”) 1 by Dr. Reddy’s Laboratories Ltd. and Dr. Reddy’s Laboratories, Inc. (collectively, “Reddy”) to market a generic version of the antibacterial drug AVELOX ® proprietary to Bayer AG, Bayer Healthcare AG, and Bayer Pharmaceuticals Corporation (collectively, “Bayer”). The active ingredient in AVELOX® is moxifloxacin hydrochloride, which is protected by, inter alia, U.S. Patent Nos. 4,990,517 (“the '517 patent”) and 5,607,942 (“the '942 patent”). Upon receiving…
2Cases cited35 opinions
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Precision Instrument Manufacturing Co. v. Automotive Maintenance MacHinery Co.Supreme Court of the United States · 1945
- Kingsdown Medical Consultants, Ltd. And E.R. Squibb & Sons, Inc. v. Hollister IncorporatedCourt of Appeals for the Federal Circuit · 1988
- Molins Plc, and John Coventry Smith, Jr. v. Textron, Inc., Kearney & Trecker Corporation, and Avco CorporationCourt of Appeals for the Federal Circuit · 1995
30 more not listed; retrieve them via the Exa API.
3Cited by1 opinion
- Buergofol GmbH v. Omega Liner Company, Inc.District Court, D. South Dakota · 2024